Hepatic Part 3 Flashcards
Preoperative considerations for the patient with acute hepatitis include
postpone elective surgery until resolved as determined by normal liver function test
-increased periop morbidity & mortality during acute phase
Perioperative considerations for patients with acute alcoholic hepatitis includes
risk with alcoholic hepatitis may not be as great
but patients could suffer from withdrawal during surgery and this is associated with a high mortality rate
Patients with hepatitis are at risk for further hepatic dysfunction and hepatic failure include
encephalopathy, coagulopathy, & hepatorenal syndrome
For patients who are chronic alcoholics, hypomagnesemia may occur
which predisposes to dysrhythmias
Lab evaluation of the patient with acute hepatitis includes
BUN, creatinine, bilirubin, electrolytes, glucose, transaminases, alkaline phosphatase, albumin, prothrombin time (INR), platelet count
serum HBsAg
blood alcohol level
Elevated transaminases do not
correlate well with the degree of cellular necrosis
bilirubin & alkaline phosphatase are usually only moderately elevated except with the cholestatic variant
For patients with acute hepatitis, describe levels of ALT & AST
ALT>AST
For patients with alcoholic hepatitis, describe levels of ALT & AST
AST> ALT
Hypoalbuminemia is usually not present except in
protracted cases with severe malnutrition (or chronic hepatitis)
The best indicator of synthetic function of the liver with hepatitis is
PT
prolongation> 3 to 4 seconds following administration of Vitamin K is indicative of severe liver dysfunction
Preoperative evaluation of the emergent patient with acute hepatitis should include:
determination of the cause & degree of hepatic impairment
record drug exposures
presence of N/V–> may necessitate cricoid pressure
correction of dehydration & electrolyte abnormalities
mental status changes suggest severe hepatic impairment
premedication generally is not given to minimize drug exposure and confounds encephalopathy in patients with advanced liver disease
Recording of drug exposures for the acute hepatic patient should include
alcohol intake, recreational drug use, recent transfusions, & prior anesthetics
For alcoholics with acute hepatitis, the preoperative evaluation includse
inappropriate behavior or obtunded patient is a sign of acute toxicity
irritability, tremulousness, HTN, and tachycardia are signs of withdrawal
Vitamin K may be necessary to correct
a coagulopathy
The goal of intraoperative management of acute hepatitis is
to preserve existing hepatic function
avoid factors that may be detrimental to the liver
Intraoperative management of the patient with acute hepatitis includes
drug selection & doses should be individualized
acute viral hepatitis may produce increased CNS sensitivity to anesthetics
Intraoperative management of the alcoholic patient includes:
display cross-tolerance to IV and volatile anesthetic agents
requires CV monitoring due to the additive depressant effects of anesthetics & alcohol, possible presence of alcoholic cardiomyopathy
Patient classification of the patient with hepatitis is based on three distinct syndromes and is determined by
liver biopsy
chronic persistent hepatitis, chronic lobular hepatitis, & chronic active hepatitis
Chronic hepatitis is defined as
persistent hepatic inflammation for longer than 6 months as evidenced by elevated serum aminotransferases
In patients with acute hepatitis, intraoperative considerations include avoiding things known to reduce hepatic blood flow such as
hypotension, excessive SNS stimulation, high mean airway pressures during controlled ventilation
Intraoperative considerations for the patient with acute hepatitis include using “standard” induction doses of IV agents since their action is
terminated by redistribution versus metabolism or excretion
-prolonged duration of action may occur if large or repeated doses of IV agents are administered (particularly opioids)
The volatile agent of choice for the patient with acute hepatitis is
isoflurane as it has the least effect on hepatic blood flow
-inhalation agents are generally preferable to IV agents due to the dependence on liver metabolism and elimination
Additional considerations for the intraoperative management of the acute hepatitis patient includes
fewest number of anesthetic agents should be used
regional anesthesia can be used in the absence of coagulopathy
Describe chronic persistent hepatitis.
present with acute hepatitis (usually B or C) that has a protracted course but eventually resolves
characterized by chronic inflammation of the portal tracts with preservation of the normal cellular architecture (don’t have a lot of cell death with this)
usually does not progress to cirrhosis
Describe chronic lobular hepatitis.
present with acute hepatitis that resolves but followed by recurrent exacerbations
-characterized by FOCI of inflammation and cellular necrosis in the lobules
usually does not progress to cirrhosis
Describe chronic active hepatitis.
occurs most commonly as a sequela of hepatitis B or C
characterized by chronic hepatic inflammation with destruction of cellular architecture
evidence of cirrhosis present initially or eventually develops
Patients with hep B or C infection usually have a favorable response to
antiviral medications
Hep B: antiviral + immune modulator drugs (interferon)
Hep C: antiviral can cure more than 95% of affected patients
Anesthetic management for the patient with chronic hepatitis includes:
patients with chronic persistent or chronic lobular hepatitis should be treated similar to those with acute hepatitis
patients with chronic active hepatitis should be assumed to have cirrhosis and treated as such
For the patient with chronic hepatitis, laboratory test may show
only mild elevation of serum aminotransferases and generally these correlate poorly with severity of the disease
Cirrhosis is a progressive disease that eventually results in
hepatic failure
Most common causes of cirrhosis include:
alcohol abuse, NALFD, chronic active hepatitis (B & C), chronic biliary inflammation or obstruction
Regardless of the cause of cirrhosis, the result is
hepatocyte necrosis followed by fibrosis and nodular regeneration (scar tissue)
Destruction of the livers normal cellular and vascular architecture in the patient with cirrhosis produces:
obstruction of the portal venous flow leading to portal hypertension
impairment of normal synthetic and metabolic functions leading to multisystem disease
3 major complications associated with cirrhosis include
variceal hemorrhage from portal hypertension
intractable fluid retention in the form of ascites
hepatic encephalopathy or coma
Approximately 10% of patients with cirrhosis have at least one episode of
bacterial peritonitis and some may eventually develop hepatocellular carcinoma
Manifestations of the patient with cirrhosis include
jaundice & ascites
other manifestations include: spider angiomas, palmar erythema, gynecomastia, spleenomegaly
Patients with cirrhosis are at increased risk for further deterioration of liver function due to
detrimental effects of anesthesia and surgery on hepatic blood flow
already limited hepatic reserve
Successful anesthetic management depends on recognizing the multisystem dysfunction with cirrhosis
GI, circulatory, pulm, renal, hematological, infections, metabolic, & neurological
the goal is to prevent or limit complications
Preoperative considerations for the patient with cirrhosis include
surgical risk is correlated with the degree of hepatic impairment
severity of hepatic impairment and surgical risk can be estimated used the Childs-Turcotte-Pugh scoring system
The Childs=Turcotte-Pugh score measures:
total bilirubin, serum albumin, INR, ascites, & hepatic encephalopathy
-assigning points based on levels and this helps determine survival
Gastrointestinal manifestations of the cirrhotic patient includes
portal hypertension leads to development of extensive venous collateral channels: gastroesophageal, hemorrhoidal, periumbilical, & retroperitoneal
The preoperative sign of portal hypertension is
abdominal wall veins
Massive bleeding from gastroesophageal varices is a major cause of morbidity & mortality and medical treatment includes
replace blood loss with IV fluids & blood products
vasopressin, somatostatin, & propranolol to reduce the rate of blood loss
balloon tamponade
endoscopic sclerosis or ligation of the varices is about 90% effective
bleeding continues or reoccurs then emergency surgery is indicated
Patients with cirrhosis may present with
anemia, thrombocytopenia/coagulopathy, leukopenia
For the patient with cirrhosis who has anemia, it is associated with
blood loss, increased RBC destruction, bone marrow suppression, & nutritional deficiencies
Thrombocytopenia/coagulopathy in the patient with cirrhosis is associated with
congestive spleenomegaly due to portal hypertension
decreased hepatic synthesis of clotting factors
enhanced fibrinolysis due to reduced elimination of factors that activate the fibrinolytic system
Leukopenia in the patient with cirrhosis is associated with
congestive spleenomegaly due to portal hypertension
Cirrhotic cardiomyopathy may be present due to
arteriovenous shunts & decreased blood viscosity
contribute to increased CO: above normal filling pressures, below normal SVR
Superimposed alcoholic cardiomyopathy may readily lead to
CHF